Total Payments
$1,881
2024 Payments
$541.86
Companies
14
Transactions
116
Medicare Patients
3,622
Medicare Billing
$228,661
Payment Breakdown by Category
Food & Beverage$1,690 (89.8%)
Education$190.97 (10.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,690 | 113 | 89.8% |
| Education | $190.97 | 3 | 10.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $649.45 | 45 | $0 (2024) |
| ABBVIE INC. | $322.95 | 27 | $0 (2024) |
| Janssen Biotech, Inc. | $173.48 | 5 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $168.44 | 9 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $156.31 | 5 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $103.63 | 7 | $0 (2023) |
| Lilly USA, LLC | $78.86 | 4 | $0 (2023) |
| LEO Pharma Inc. | $75.34 | 4 | $0 (2023) |
| GENZYME CORPORATION | $46.85 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $38.47 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $541.86 | 40 | ABBVIE INC. ($220.36) |
| 2023 | $621.03 | 31 | Amgen Inc. ($162.72) |
| 2022 | $474.30 | 29 | Amgen Inc. ($216.55) |
| 2021 | $243.39 | 16 | Amgen Inc. ($72.85) |
All Payment Transactions
116 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.05 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Inflammation | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.86 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.84 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Inflammation | ||||||
| 10/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Immunology | ||||||
| 10/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.56 | General |
| Category: IMMUNOLOGY | ||||||
| 10/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.92 | General |
| Category: Immunology | ||||||
| 10/08/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: Inflammation | ||||||
| 10/02/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Inflammation | ||||||
| 09/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.52 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: IMMUNOLOGY | ||||||
| 09/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.25 | General |
| Category: IMMUNOLOGY | ||||||
| 08/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.71 | General |
| Category: IMMUNOLOGY | ||||||
| 08/13/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: Inflammation | ||||||
| 08/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.75 | General |
| Category: IMMUNOLOGY | ||||||
| 08/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.87 | General |
| Category: IMMUNOLOGY | ||||||
| 07/29/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Inflammation | ||||||
| 07/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.73 | General |
| Category: IMMUNOLOGY | ||||||
| 07/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.91 | General |
| Category: IMMUNOLOGY | ||||||
| 06/26/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Inflammation | ||||||
| 06/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.01 | General |
| Category: IMMUNOLOGY | ||||||
| 06/11/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $7.00 | General |
| Category: Inflammation | ||||||
| 06/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $28.81 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,047 | 1,499 | $228,478 | $62,283 |
| 2022 | 13 | 985 | 1,582 | $223,499 | $65,934 |
| 2021 | 12 | 874 | 1,269 | $206,514 | $61,342 |
| 2020 | 9 | 716 | 1,073 | $135,686 | $39,101 |
Total Patients
3,622
Total Services
5,423
Medicare Billing
$228,661
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 279 | 340 | $58,786 | $16,099 | 27.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 150 | 194 | $48,508 | $13,071 | 26.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 101 | 120 | $26,062 | $7,461 | 28.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 116 | 128 | $25,290 | $6,484 | 25.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 59 | 59 | $18,935 | $5,353 | 28.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 109 | 131 | $16,677 | $4,470 | 26.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 73 | 73 | $15,685 | $3,449 | 22.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 38 | 49 | $4,674 | $1,503 | 32.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 71 | 353 | $4,410 | $1,427 | 32.4% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 19 | 19 | $4,414 | $1,288 | 29.2% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 11 | 11 | $2,618 | $898.81 | 34.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 21 | 22 | $2,420 | $777.84 | 32.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 234 | 308 | $54,565 | $16,231 | 29.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 145 | 201 | $50,258 | $14,459 | 28.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 124 | 137 | $27,068 | $8,120 | 30.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 120 | 151 | $19,675 | $6,100 | 31.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 77 | 79 | $17,157 | $5,039 | 29.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 66 | 66 | $14,498 | $4,306 | 29.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 41 | 41 | $13,460 | $3,781 | 28.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 92 | 492 | $6,337 | $2,073 | 32.7% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2022 | 14 | 18 | $4,599 | $1,397 | 30.4% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2022 | 17 | 23 | $5,470 | $1,365 | 24.9% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 11 | 11 | $3,815 | $1,299 | 34.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 31 | 42 | $4,151 | $1,282 | 30.9% |
| 69100 | Biopsy of ear | Office | 2022 | 13 | 13 | $2,444 | $481.24 | 19.7% |
About Stephanie Rhodebeck, N.P
Stephanie Rhodebeck, N.P is a Nurse Practitioner healthcare provider based in Dublin, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/07/2011. The National Provider Identifier (NPI) number assigned to this provider is 1295031458.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Stephanie Rhodebeck, N.P has received a total of $1,881 in payments from pharmaceutical and medical device companies, with $541.86 received in 2024. These payments were reported across 116 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,690).
As a Medicare-enrolled provider, Rhodebeck has provided services to 3,622 Medicare beneficiaries, totaling 5,423 services with total Medicare billing of $228,661. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Dublin, OH
- Active Since 02/07/2011
- Last Updated 12/28/2015
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1295031458
Products in Payments
- Otezla (Drug) $604.12
- SKYRIZI (Biological) $310.17
- TREMFYA (Drug) $173.48
- Sotyktu (Drug) $168.44
- DUPIXENT (Biological) $136.45
- TALTZ (Drug) $78.86
- ADBRY (Biological) $75.34
- ILUMYA (Biological) $50.33
- Enbrel (Biological) $45.33
- COSENTYX (Biological) $38.47
- EUCRISA (Drug) $16.33
- VTAMA (Drug) $14.84
- LIBTAYO (Biological) $14.03
- NUZYRA (Drug) $13.76
- RINVOQ (Biological) $12.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Dublin
Laurie Rosales, Aprn-Cnp, APRN-CNP
Nurse Practitioner — Payments: $29,518
Nurse Practitioner $29,518
Navonda Blackwell
Nurse Practitioner — Payments: $5,649
Nurse Practitioner $5,649
Kyle Smith, Np, NP
Nurse Practitioner — Payments: $2,921
Nurse Practitioner $2,921
Hayley Helmer, Fnp, FNP
Nurse Practitioner — Payments: $2,230
Nurse Practitioner $2,230
Jennifer Sullivan, N.p, N.P
Nurse Practitioner — Payments: $2,081
Nurse Practitioner $2,081
Kathryn Tloczynski, Np, NP
Nurse Practitioner — Payments: $1,681
Nurse Practitioner $1,681